Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SPRB - Spruce Biosciences Resumes Trading on the Nasdaq Capital Market

SPRB - Spruce Biosciences Resumes Trading on the Nasdaq Capital Market

Spruce Biosciences Inc.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it will resume trading on the Nasdaq Capital Market at the market open today, September 15, 2025, under the ticker symbol “SPRB” and CUSIP 85209E 208.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. To learn more, visit www.sprucebio.com and follow us on X , LinkedIn , Facebook and YouTube .

View source version on businesswire.com: https://www.businesswire.com/news/home/20250915439985/en/

Spruce Media
Katie Beach Oltsik
Inizio Evoke Comms
(937) 232-4889
Katherine.Beach@inizioevoke.com
media@sprucebio.com

Spruce Investors
Samir Gharib
President and CFO
Spruce Biosciences, Inc.
investors@sprucebio.com

Stock Information
Company Name: Spruce Biosciences Inc.
Stock Symbol: SPRB
Market: NASDAQ
Website: sprucebiosciences.com
Menu
SPRB SPRB Quote SPRB Short SPRB News SPRB Articles SPRB Message Board
Get SPRB Alerts

News, Short Squeeze, Breakout and More Instantly...